Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice

Journal of Clinical Investigation

Volumn 113, Issue 6, 2004, Pages 867-875

  Tang, Xiuwei ^a   Kim, Arianna L ^a   Feith, David J ^b   Pegg, Anthony E ^b   Russo, Justin ^a   Zhang, Hong ^a   Aszterbaum, Michelle ^c   Kopelovich, Levy ^d   Epstein Jr , Ervin H ^c   Bickers, David R ^a   Athar, Mohammad ^a  

^a Columbia University ^*  (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIZYME; EFLORNITHINE; KERATIN; KERATIN 6; ORNITHINE DECARBOXYLASE; POLYAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CELL CARCINOMA; CARCINOGENESIS; CELL MUTANT; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; GENE MUTATION; GENE OVEREXPRESSION; HAIR FOLLICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PTCH1 GENE; SKIN; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; ULTRAVIOLET B RADIATION;

ANIMALS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; EFLORNITHINE; HETEROZYGOTE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; ORNITHINE DECARBOXYLASE; RECEPTORS, CELL SURFACE; ULTRAVIOLET RAYS;

EID: 11144358643     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200420732     Document Type: Article

References (66)

1. Miller, D.L., and Weinstock, M.A. 1994. Non-melanoma skin cancer in the United States: incidence. J. Am. Acad. Dermatol. 30:774-778.
2. Dlugosz, A., Merlino, G., and Yuspa, S.H. 2002. Progress in cutaneous cancer research. J. Investig. Dermatol. Symp. Proc. 7:17-26.
3. Giglia-Mari, G., and Sarasin, A. 2003. TP53 mutations in human skin cancers. Hum. Mutat. 21:217-228.
4. Gorlin, R.J. 1987. Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore). 66:98-113.
5. Daya-Grosjean, L., and Sarasin, A. 2000. UV-specific mutations of the human patched gene in basal cell carcinomas from normal individuals and xeroderma pigmentosum patients. Mutat. Res. 450:193-199.
6. Bodak, N., et al. 1999. High levels of patched gene mutations in basal cell carcinomas from patients with xeroderma pigmentosum. Proc. Natl. Acad. Sci. U. S. A. 96:5117-5122.
7. Bonifas, J.M., et al. 2001. Activation of expression of hedgehog target genes in basal cell carcinomas. J. Invest. Dermatol. 116:739-742.
8. Couve-Privat, S., Bouadjar, B., Avril, M.F., Sarasin, A., and Daya-Grosjean, L. 2002. Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer Res. 62:7186-7189.
9. Gailani, M.R., and Bale, A.E. 1999. Acquired and inherited basal cell carcinomas and the patched gene. Adv. Dermatol. 14:261-283.
10. Xie, J., et al. 1998. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature. 391:90-92.
11. Saldanha, G. 2001. The Hedgehog signalling pathway and cancer. J. Pathol. 193:427-432.
12. Bale, A.E., and Yu, K.P. 2001. The hedgehog pathway and basal cell carcinomas. Hum. Mol. Genet. 10:757-762.
13. Sarasin, A. 1999. The molecular pathways of ultraviolet-induced carcinogenesis. Mutat. Res. 428:5-10.
14. Goodrich, L.V., Milenkovic, L., Higgins, K.M., and Scott, M.P. 1997. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science. 277:1109-1113.
15. Asztetbaum, M., Beech, J., and Epstein, E.H., Jr. 1999. Ultraviolet radiation mutagenesis of hedgehog pathway genes in basal cell carcinomas. J. Investig. Dermatol. Symp. Proc. 4:41-45.
16. Aszterbaum, M., et al. 1999. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat. Med. 5:1285-1291.
17. Pegg, A.E. 1988. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 48:759-774.
18. Pegg, A.E., et al. 2003. Transgenic mouse models for studies of the role of polyamines in normal, hypertrophic and neoplastic growth. Biochem. Soc. Trans. 31:356-360.
19. Smith, M.K., Trempus, C.S., and Gilmour, S.K. 1998. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin. Carcinogenesis. 19:1409-1415.
20. Scalabrino, G., et al. 1980. Levels of activity of the polyamine biosynthetic decarboxylases as indicators of degree of malignancy of human cutaneous epitheliomas. J. Invest. Dermatol. 74:122-124.
21. O'Brien, T.G., Simsiman, R.C., and Boutwell, R.K. 1975. Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res. 35:1662-1670.
22. Clifford, A., Morgan, D., Yuspa, S.H., Soler, A.P., and Gilmour, S. 1995. Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res. 55:1680-1686.
23. O'Brien, T.G., Megosh, L.C., Gilliard, G., and Soler, A.P. 1997. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res. 57:2630-2637.
24. Megosh, L.C., Hu, J., George, K., and O'Brien, T.G. 2002. Genetic control of polyamine-dependent susceptibility to skin tumorigenesis. Genomics. 79:505-512.
25. Ahmad, N., Gilliam, A.C., Katiyar, S.K., O'Brien, T.G., and Mukhtar, H. 2001. A definitive role of orithine decarboxylase in photocarcinogenesis. Am. J. Pathol. 159:885-892.
26. Gokmen, S.S., Aygit, A.C., Ayhan, M.S., Yorulmaz, F., and Gulen, S. 2001. Significance of arginase and ornithine in malignant tumors of the human skin. J. Lab. Clin. Med. 137:340-344.
27. Kagoura, M., Toyoda, M., Matsui, C., and Motohashi, M. 2000. Immunohistochemical localization of ornithine decarboxylase in skin tumors. J. Cutan. Pathol. 27:338-343.
28. Hillary, R.A., and Pegg, A.E. 2003. Decarboxylases involved in polyamine biosynthesis and their inactivation by nitric oxide. Biochim. Biophys. Acta. 1647:161-166.
29. Coffino, P. 2001. Regulation of cellular polyamines by antizyme. Nat. Rev. Mol. Cell Biol. 2:188-194.
30. Hayashi, S., Murakami, Y., and Marsufuji, S. 1996. Ornithine decarboxylase antizyme: a novel type of regulatory protein. Trends Biochem. Sci. 21:27-30.
31. Feith, D.J., Shantz, L.M., and Pegg, A.E. 2001. Targeted antizyme expression in the skin of transgenic mice reduces rumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis. Cancer Res. 61:6073-6081.
32. Kim, A.L., Athar, M., Bickers, D.R., and Gautier, J. 2002. Stage-specific alterations of cyclin expression during UVB-induced murine skin tumor development. Photochem. Photobiol. 75:58-67.
33. Zhao, J., et al. 1999. Photoprotective effect of black tea extracts against UVB-induced phototoxicity in skin. Photochem. Photobiol. 70:637-644.
34. Fischer, S.M., Lee, M., and Lubet, R.A. 2001. Difluoromethylornithine is effective as both a preventive and therapeutic agent against the development of UV carcinogenesis in SKH hairless mice. Carcinogenesis. 22:83-88.
35. Smith, M.K., et al. 1997. Ornithine decarboxylase overexpression leads to increased epithelial tumor invasiveness. Cancer Res. 57:2104-2108.
36. Grachtchouk, M., et al. 2000. Basal cell carcinomas in mice overexpressing Gil2 in skin. Nat. Genet. 24:216-217.
37. Pegg, A.E., Shantz, L.M., and Coleman, C.S. 1995. Ornithine decarboxylase as a target for chemoprevention. J. Cell. Biochem. Suppl. 22:132-138.
38. Ramirez, A., Vidal, M., Bravo, A., and Jorcano, J.L. 1998. Analysis of sequences controlling tissue-specific and hyperproliferation-related keratin 6 gene expression in transgenic mice. DNA Cell Biol. 17:177-185.
39. Seiler, N. 2003. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives. Curr. Drug Targets. 4:565-585.
40. Seiler, N. 2003. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. Curr. Drug Targets. 4:537-564.
41. Arbeit, J.M., et al. 1999. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice. Cancer Res. 59:3610-3620.
42. Carbone, P.P., et al. 1998. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine. Cancer Epidemiol. Biomarkers Prev. 7:907-912.
43. Carbone, P.P., et al. 2001. Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants. Cancer Epidemiol. Biomarkers Prev. 10:657-661.
44. Shantz, L.M., Guo, Y., Sawicki, J.A., Pegg, A.E., and O'Brien, T.G. 2002. Overexpression of a dominant-negative ornithine decarboxylase in mouse skin: effect on enzyme activity and papilloma formation. Carcinogenesis. 23:657-664.
45. Bickers, D.R., and Athar, M. 2000. Novel approaches to chemoprevention of skin cancer. J. Dermatol. 27:691-695.
46. Einspaht, J.G., Bowden, G.T., and Alberts, D.S. 2003. Skin cancer chemoprevention: strategies to save our skin. Recent Results Cancer Res. 163:151-164.
47. Corsarelis, G., Sun, T.T., and Lavker, R.M. 1990. Label retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell. 61:1329-1337.
48. Owens, D.M., and Watt, F.M. 2003. Contribution of stem cells and differentiated cells to epidermal tumours. Nat. Rev. Cancer. 3:444-451.
49. Taylor, G., Lehrer, M.S., Jensen, P.J., Sun, T.T., and Lavker, R.M. 2000. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 102:451-461.
50. Alonso, L., and Fuchs, E. 2003. Stem cells of the skin epithelium. Proc. Natl. Acad. Sci. U. S. A. 100(Suppl. 1):11830-11835.
51. Wheeler, D.L., Ness, K.J., Oberley, T.D., and Verma, A.K. 2003. Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss. Cancer Res. 63:3037-3042.
52. Bale, S.J., Falk, R.T., and Rogers, G.R. 1998. Parching together the genetics of Gorlin syndrome. J. Cutan. Med. Surg. 3:31-34.
53. el Murradi, A., Grehan, D., Toner, M., and McCartan, B.E. 1996. Proliferating cell nuclear antigen staining in syndrome and nonsyndrome odontogenic keratocysts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 81:217-220.
54. Li, T.J., Browne, R.M., and Matthews, J.B. 1995. Epithelial cell proliferation in odontogenic keratocysts: a comparative immunocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome (BCNS)-associated lesions. J. Oral Pathol. Med. 24:221-226.
55. Maiolino, P., Restucci, B., and De Vico, G. 1995. Expression of proliferating cell nuclear antigen in basal cell carcinomas and in squamous cell carcinomas of canine skin: correlation with mitotic index and histological features. Zentralbl. Veterinarmed. A. 42:339-343.
56. Barreto, D.C., Bale, A.E., De Marco, L., and Gomez, R.S. 2002. Immunolocalization of PTCH protein in odontogenic cysts and tumors. J. Dent. Res. 81:757-760.
57. Barreto, D.C., Gomez, R.S., Bale, A.E., Boson, W.L., and De Marco, L. 2000. PTCH gene mutations in odontogenic keratocysts. J. Dent. Res. 79:1418-1422.
58. Toth, D.P., Guenther, L.C., and Shum, D.T. 1996. Proliferating cell nuclear antigen (PCNA): prognostic value in the clinical recurrence of primary basal cell carcinoma. J. Dermatol. Sci. 11:36-40.
59. Hickman, J.G., Huber, F., and Palmisano, M. 2001. Human dermal safety studies with eflornithine HCl 13.9% cream (Vaniqa), a novel treatment for excessive facial hair. Curr. Med. Res. Opin. 16:235-244.
60. Xie, J., et al. 2001. A role of PDGFRalpha in basal cell carcinoma proliferation. Proc. Natl. Acad. Sci. U. S. A. 98:9255-9259.
61. Thyberg, J., and Fredholm, B.B. 1987. Induction of ornithine decarboxylase activity and putrescine synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. Exp. Cell Res. 170:160-169.
62. Neill, G.W., et al. 2003. Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma. Cancer Res. 63:4692-4697.
63. Kaczmarek, L, Calabretta, B., Ferrari, S., and de Riel, J.K. 1987. Cell-cycle-dependent expression of human ornithine decarboxylase. J. Cell. Physiol. 132:545-551.
64. Gilmour, S.K., Birchler, M., Smith, M.K., Rayca, K., and Mostochuk, J. 1999. Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin. Cell Growth Differ. 10:739-748.
65. Epstein, E., Jr. 2001. Genetic determinants of basal cell carcinoma risk. Med. Pediatr. Oncol. 36:555-558.
66. Wicking, C., Smyth, I., and Bale, A. 1999. The hedge-hog signalling pathway in tumorigenesis and development. Oncogene. 18:7844-7851.